News Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVAC Read more » September 26, 2024
News Second call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates in a mouse model Read more » May 7, 2024
News University of Oxford (UOXF) starts aligned clinical study – first participant enrolled Read more » April 26, 2024
News MTBVAC, the first vaccine against Tuberculosis derived from a human source, begins clinical trials in adults in India. Read more » March 24, 2024
